LEADER 02079nam  2200397   450 
001 9910583044303321
005 20230120002906.0
010   $a0-323-54836-9
035   $a(CKB)4100000007200431
035   $a(MiAaPQ)EBC5609799
035   $a(EXLCZ)994100000007200431
100   $a20181224d2019      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBiomarkers in cardiovascular disease /$fedited by Vijay Nambi
210  1$aSt. Louis, Missouri :$cElsevier,$d[2019]
210  4$dİ2019
215   $a1 online resource (199 pages)
311   $a0-323-54835-0 
327   $aLab standards: a practical guide for clinicians -- Statistical interpretation of the utility and value of a biomarker -- Hypertension: key markers of injury and prognosis -- Diabetes: key markers of injury and prognosis -- Advanced lipid testing -- HDL and HDL cholesterol -- Inflammation and CVD: state of science -- Cardiac injury, maladaptation, and heart failure Incidence -- Biomarkers to assess and guide the management of heart failure -- Biomarkers to assess and guide the management of acute coronary syndrome -- Biomarkers to assist in the evaluation of chest pain: a practical guide -- Biomarkers to assist in the evaluation of shortness of breath: a practical guide -- Anti-platelet therapy: role of biomarkers -- Biomarkers in the management of venous thrombosis -- Metabolomics, proteomics, and genomics: an introduction for the clinician -- A peek into the future: how biomarkers may guide us in the future.
606   $aCardiovascular system$xDiseases$xDiagnosis
606   $aBiochemical markers$xDiagnostic use
615  0$aCardiovascular system$xDiseases$xDiagnosis.
615  0$aBiochemical markers$xDiagnostic use.
676   $a616.1
702   $aNambi$b Vijay
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910583044303321
996   $aBiomarkers in cardiovascular disease$92076591
997   $aUNINA